Clinical Trial Update: Image Guided Surgery for Margin Assessment of Head and Neck Cancer Using Cetuximab-IRDye800CW cONjugate [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating image-guided surgery using Cetuximab-IRDye800CW for margin assessment in head and neck squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cetuximab-IRDye800CW

Snippet

Sponsor: University Medical Center Groningen | Conditions: Head and Neck Squamous Cell Carcinoma, Margin Assessment | Phase 1, Phase 2 | Status: UNKNOWN